Stenosis of the Mitral Valve

Overview

Mitral valve stenosis (MVS) is a narrowing of the mitral valve opening, the valve between the left atrium and the left ventricle of the heart. When the valve does not open fully, blood flow from the atrium to the ventricle is restricted, causing increased pressure in the left atrium and pulmonary circulation.

• Typical age group: Most cases are diagnosed in adults aged 40–70, but the condition can appear at any age.
• Gender: Women are affected ~1.5 times more often than men, largely because rheumatic fever—a leading cause—historically has a higher incidence in females.
• Prevalence: In the United States, rheumatic mitral stenosis accounts for <1 % of all heart‑valve disease patients, but it remains common in low‑income regions where rheumatic fever is still prevalent (up to 5 % of the adult population in some parts of sub‑Saharan Africa and South Asia) ¹.
• Geography: Developed countries see most cases resulting from degenerative calcification, while developing nations still confront rheumatic origins.

Symptoms

The clinical picture varies with the severity of the narrowing and how fast it progresses. Early disease may be silent, but classic symptoms develop as the left atrial pressure rises.

• Dyspnea on exertion (shortness of breath): Often the first complaint; worsens with activity or when lying flat (orthopnea).
• Fatigue and reduced exercise tolerance: The heart cannot fill adequately, leading to low cardiac output.
• Palpitations: Frequently due to atrial fibrillation (AFib), a common arrhythmia in MVS.
• Chest discomfort: Not typical angina, but a feeling of pressure may occur during strenuous effort.
• Cough and hemoptysis: Elevated pulmonary venous pressure can cause a dry cough or, rarely, coughing up blood.
• Swelling of the ankles or abdomen (edema): Signifies right‑sided heart failure secondary to longstanding pulmonary hypertension.
• Syncope or near‑syncope: May happen during exertion when cardiac output cannot meet demand.
• Weight loss, loss of appetite: Chronic congestive symptoms can affect nutrition.

Causes and Risk Factors

Primary Causes

1. Rheumatic fever: Autoimmune reaction after infection with group A Streptococcus. Scarring and thickening of the valve leaflets cause the classic restrictive lesion. Still the leading cause worldwide.
2. Degenerative (calcific) stenosis: With aging, calcium deposits build up on the mitral annulus and leaflets, especially in patients with chronic kidney disease or metabolic bone disease.
3. Congenital mitral stenosis: Rare malformations present from birth.

Risk Factors

• History of rheumatic fever or untreated streptococcal throat infection
• Female sex
• Age > 50 years (for degenerative calcification)
• Chronic kidney disease or dialysis (accelerates calcification)
• Radiation therapy to the chest (e.g., for lymphoma) – may cause fibrosis
• Family history of early‑onset valve disease
• Other rheumatic heart lesions (e.g., mitral regurgitation, aortic stenosis)

Diagnosis

Accurate diagnosis requires a combination of history, physical examination, and imaging studies.

Physical Exam Findings

• Opening snap: A high‑pitched sound heard shortly after S2, indicating sudden valve opening.
• Diastolic rumble: Low‑frequency murmur best heard at the apex with the patient in left lateral decubitus.
• Signs of pulmonary hypertension (e.g., loud P2) or right‑sided heart failure (jugular venous distension).

Imaging & Tests

1. Transthoracic echocardiography (TTE): First‑line; measures mitral valve area (MVA);
    – MVA ≥ 2 cm² = mild, 1.5–2 cm² = moderate, ≤ 1.5 cm² = severe stenosis.
2. Transesophageal echocardiography (TEE): Provides clearer images, especially when TTE windows are limited.
3. Cardiac catheterization: Invasive measurement of pressure gradients; used when non‑invasive data are ambiguous.
4. Stress echocardiography or exercise testing: Evaluates functional capacity and pulmonary artery pressure response.
5. Chest X‑ray: May show left atrial enlargement, pulmonary venous congestion, or calcification of the valve.
6. Electrocardiogram (ECG): Detects atrial fibrillation, left atrial enlargement, or right‑ventricular strain.
7. Blood tests: Routine labs, plus anti‑streptolysin O (ASO) titres if rheumatic etiology is suspected.

Treatment Options

Treatment is tailored to severity, symptom burden, and comorbidities.

Medical Management

• Diuretics: Loop diuretics (e.g., furosemide) reduce pulmonary congestion.
<
• Beta‑blockers or calcium‑channel blockers: Slow heart rate, allowing longer diastolic filling (particularly useful in atrial fibrillation).
• Anticoagulation: Indicated for patients with atrial fibrillation, prior thromboembolism, or a left atrial thrombus—warfarin (INR 2–3) or a DOAC if no contraindication.
• Rate control for AFib: Digoxin, diltiazem, or amiodarone as needed.
• Prophylactic antibiotics: Not routinely recommended; only for dental procedures in patients with prior infective endocarditis or prosthetic valve replacement.

Interventional & Surgical Options

1. Percutaneous balloon mitral commissurotomy (PBMC): First‑line for symptomatic severe stenosis with pliable valve leaflets and no significant mitral regurgitation. Success rates > 85 % in suitable candidates ².
2. Open mitral valve replacement (MVR): Indicated when the valve is heavily calcified, has severe regurgitation, or PBMC is contraindicated. Mechanical prostheses require lifelong anticoagulation; bioprosthetic valves have limited durability but avoid chronic anticoagulation.
3. Mitral valve repair: Less common for pure stenosis but may be performed when concurrent regurgitation is present.
4. Hybrid approaches: Emerging catheter‑based techniques (e.g., transcatheter mitral valve implantation) are under investigation for high‑risk surgical patients.

Lifestyle & Supportive Measures

• Low‑sodium diet (< 2 g/day) to lessen fluid retention.
• Fluid restriction (1.5–2 L/day) in patients with advanced heart failure.
• Regular, moderate aerobic activity (e.g., walking) as tolerated; avoid extreme exertion that provokes severe dyspnea.
• Weight management to lower cardiac workload.
• Vaccinations (influenza, pneumococcal, COVID‑19) to prevent respiratory infections that can worsen pulmonary pressures.

Living with Stenosis of the Mitral Valve

Daily Management Tips

• Medication adherence: Use a weekly pill organizer and set alarms.
• Monitor symptoms: Keep a log of shortness of breath, weight changes, and palpitations.
• Daily weight: A gain of > 2 lb (≈ 1 kg) in 24 hours may signal fluid overload.
• Salt awareness: Read nutrition labels; avoid processed foods, canned soups, and sauces high in sodium.
• Exercise safely: Warm‑up slowly; if you become disproportionately breathless, pause and rest.
• Travel considerations: Carry a copy of your cardiac history, medication list, and a small supply of diuretics for altitude or long‑haul flights.
• Support network: Join a heart‑failure or valve‑disease support group; sharing experiences can improve coping.

Follow‑up Schedule

After diagnosis, most patients need echocardiography every 6–12 months if asymptomatic, or sooner if symptoms change. Those with implanted prosthetic valves require routine INR checks (if mechanical) and annual imaging.

Prevention

Because many cases arise from rheumatic fever, primary prevention targets the underlying infection.

• Prompt treatment of strep throat: Complete a full course of penicillin or an appropriate alternative.
• Secondary prophylaxis: For individuals with a prior rheumatic fever episode, monthly benzathine penicillin G (or oral antibiotics if allergic) for ≥ 10 years or until age 40, whichever is longer, reduces recurrence risk ³.
• Control of risk factors for calcific stenosis: Manage chronic kidney disease, keep calcium‑phosphate balance in check, and avoid excessive vitamin D supplementation without monitoring.
• Healthy lifestyle: Regular exercise, balanced diet, and smoking cessation lower overall cardiovascular risk.

Complications

If untreated, mitral stenosis can progress to serious, sometimes life‑threatening conditions.

• Atrial fibrillation: Occurs in up to 30 % of patients with moderate–severe stenosis; increases stroke risk.
• Stroke and systemic embolism: Stagnant blood in the enlarged left atrium predisposes to clot formation.
• Pulmonary hypertension: Chronic pressure overload leads to right‑ventricular failure.
• Right‑sided (cor pulmonale) heart failure: Presents with peripheral edema, hepatic congestion, and ascites.
• Endocarditis: Damaged valve tissue is a nidus for bacterial infection.
• Pregnancy complications: Women with severe MVS have higher rates of fetal loss, pre‑eclampsia, and maternal heart failure.

When to Seek Emergency Care

If you experience any of the following, call emergency services (911 in the U.S.) or go to the nearest emergency department immediately:

• Sudden or severe shortness of breath at rest.
• Chest pain or pressure that does not improve with rest.
• Rapid onset of palpitations accompanied by dizziness, fainting, or loss of consciousness.
• Sudden swelling of the legs, abdomen, or rapid weight gain (> 2 lb/ 1 kg in 24 hours).
• Evidence of a stroke – sudden weakness, facial droop, speech difficulty, or vision loss.
• Persistent coughing up blood (hemoptysis).
• Severe fatigue that prevents you from performing basic activities of daily living.

References

1. World Health Organization. Rheumatic heart disease. 2022. WHO.
2. Bonow RO, et al. 2022 ACC/AHA Guideline for the Management of Valvular Heart Disease. J Am Coll Cardiol. 2022;79:e1‑e71.
3. Carapetis JR, et al. The global burden of rheumatic heart disease. Nat Rev Cardiol. 2021;18:286‑301.
4. Mayo Clinic. Mitral valve stenosis. 2023. Mayo Clinic.
5. Cleveland Clinic. Mitral Stenosis Treatment Options. 2024. Cleveland Clinic.
6. National Heart, Lung, and Blood Institute. Heart Valve Problems. 2023. NIH.